Os01g0928700 Antibody

What is Os01g0928700 and why is it significant in plant research?

Os01g0928700 is a protein encoded by the Os01g0928700 gene in Oryza sativa subsp. japonica (rice). The protein is significant in plant research as it represents one of the many proteins being studied to understand rice biology, development, and potential agricultural applications. Research on rice proteins like Os01g0928700 contributes to our understanding of plant biology and can inform efforts in crop improvement and stress resistance. The antibody against this protein serves as a vital tool for detecting and quantifying the protein in various experimental contexts .

What are the primary applications of the Os01g0928700 antibody?

The Os01g0928700 antibody has been validated for several key applications in plant molecular biology research:

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of the target protein in solution

• Western Blotting (WB): For detection of the protein in cell or tissue lysates

These applications allow researchers to study protein expression, localization, and function in various experimental contexts . The antibody's versatility makes it valuable for both quantitative and qualitative analyses in rice research.

What quality control parameters should be considered when using the Os01g0928700 antibody?

When working with the Os01g0928700 antibody, researchers should consider several quality control parameters:

• Positive and negative controls: The antibody kit includes 200μg of antigens as positive control and 1ml pre-immune serum as negative control, which should be incorporated into experimental designs .

• Antibody specificity: Validate that the antibody specifically recognizes Os01g0928700 and not other proteins. Cross-reactivity testing is essential, particularly when working with related plant species.

• Signal-to-noise ratio: Optimize antibody concentration to achieve strong specific signals while minimizing background noise, similar to optimization approaches used in other ELISA systems .

• Reproducibility: Ensure consistent results across multiple experiments by standardizing protocols and using the same lot of antibody when possible.

• Storage conditions: Maintain antibody at -20°C or -80°C to preserve functionality and avoid repeated freeze-thaw cycles .

How should the Os01g0928700 antibody be stored to maintain its reactivity?

The Os01g0928700 antibody should be stored at either -20°C or -80°C to maintain its reactivity and functionality . Proper storage is crucial for antibody performance and reliability in experimental applications. Researchers should consider the following best practices:

• Aliquot the antibody upon receipt to minimize freeze-thaw cycles, which can degrade antibody quality

• Store aliquots in appropriate volumes for single-use applications

• Avoid exposing the antibody to room temperature for extended periods

• Follow manufacturer guidelines for thawing procedures

• Document storage conditions and duration as part of experimental records

Proper storage ensures consistent antibody performance across experiments and maximizes the useful lifespan of the reagent.

How can Os01g0928700 antibody be validated for cross-reactivity with homologous proteins from other plant species?

Validating Os01g0928700 antibody for cross-reactivity with homologous proteins from other plant species requires a systematic approach:

• Sequence alignment analysis: Compare the immunogen sequence (Oryza sativa subsp. japonica Os01g0928700) with potential homologs in target species to predict potential cross-reactivity based on epitope conservation.

• Western blotting validation: Perform Western blotting using protein extracts from multiple plant species, including:

  • Positive control: Rice (Oryza sativa) extract

  • Test samples: Extracts from related species (other grasses or cereals)

  • Negative control: Extracts from distant plant species

• Blocking peptide competition: If cross-reactivity is observed, confirm specificity by pre-incubating the antibody with the immunizing peptide to block specific binding.

• Immunoprecipitation followed by mass spectrometry: To definitively identify cross-reactive proteins in other species.

This validation approach is similar to techniques used for other plant antibodies and follows standard immunological validation protocols comparable to those used for human antibodies in medical research .

What are the potential challenges in using the Os01g0928700 antibody for co-immunoprecipitation experiments?

Using the Os01g0928700 antibody for co-immunoprecipitation (Co-IP) experiments presents several challenges that researchers should address:

• Antibody orientation and binding site: The affinity-purified polyclonal nature of this antibody means it contains antibodies recognizing multiple epitopes, which can be advantageous for immunoprecipitation but may potentially interfere with protein-protein interactions of interest.

• Native protein conformation preservation: The antibody was raised against a recombinant protein , so researchers must ensure that the antibody recognizes the native protein conformation in the conditions used for Co-IP.

• Antibody immobilization: Determine optimal methods for antibody immobilization (e.g., directly coupling to beads or using Protein A/G) that maintain antibody functionality while minimizing background.

• Buffer optimization: Identify buffer conditions that preserve both antibody-antigen binding and protein-protein interactions of interest, which may require balancing ionic strength, detergent concentration, and pH.

• Validation controls: Include appropriate controls such as:

  • Input control (pre-immunoprecipitation sample)

  • IgG control (non-specific rabbit IgG)

  • Pre-immune serum control (provided with the antibody)

  • Reverse Co-IP validation

These challenges parallel those encountered in other immunoprecipitation studies, though they must be specifically optimized for plant protein research contexts.

How do avidity and specificity considerations affect the interpretation of Os01g0928700 antibody results in complex plant samples?

Avidity and specificity are critical parameters that significantly impact the interpretation of Os01g0928700 antibody results when analyzing complex plant samples:

Understanding these factors is essential for accurate interpretation of experimental results, particularly when analyzing proteins expressed at varying levels across different plant tissues or developmental stages.

What is the optimal protocol for using Os01g0928700 antibody in Western blotting applications?

The optimal protocol for using Os01g0928700 antibody in Western blotting applications requires careful optimization and attention to detail:

• Sample preparation:

  • Extract plant proteins using a buffer containing protease inhibitors

  • Quantify protein concentration using Bradford or BCA assay

  • Load 20-40 μg total protein per lane

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal separation

  • Include molecular weight markers

  • Include positive control (provided antigen, 200μg)

• Transfer conditions:

  • Transfer to PVDF or nitrocellulose membrane at 100V for 1 hour or 30V overnight

  • Verify transfer efficiency with reversible stain (Ponceau S)

• Blocking:

  • Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Primary antibody incubation:

  • Dilute Os01g0928700 antibody 1:1000-1:2000 in blocking solution

  • Incubate overnight at 4°C with gentle agitation

• Washing:

  • Wash membrane 3-4 times with TBST, 5-10 minutes each

• Secondary antibody incubation:

  • Use anti-rabbit IgG-HRP at 1:5000-1:10000 dilution

  • Incubate for 1 hour at room temperature

• Detection:

  • Develop using chemiluminescent substrate

  • Expose to X-ray film or image using digital imager

• Controls and validation:

  • Include pre-immune serum as negative control

  • Consider performing a neutralization test using the recombinant antigen

This protocol is consistent with established Western blotting methodologies but optimized for plant protein detection with the Os01g0928700 antibody.

How should ELISA protocols be optimized when using the Os01g0928700 antibody?

Optimizing ELISA protocols for the Os01g0928700 antibody requires systematic adjustment of multiple parameters for reliable quantification:

• ELISA format selection:

  • Direct ELISA: Simplest approach, coating antigen directly onto plate

  • Indirect ELISA: More sensitive, detecting antigen with primary then secondary antibody

  • Sandwich ELISA: Highest specificity, using capture and detection antibodies

• Plate coating optimization:

  • Concentration: Test coating buffer concentrations (50mM carbonate buffer, pH 9.6)

  • Incubation time: Typically 16 hours at 4°C or 2 hours at 37°C

  • Blocking agent: 1-5% BSA or non-fat dry milk in PBS

• Antibody concentration optimization:

  • Perform checkerboard titration to determine optimal antibody concentration

  • Starting dilution range: 0.5-2.0μg/ml for Os01g0928700 antibody

  • Test multiple dilutions to establish standard curve

• Sample preparation considerations:

  • Extraction buffer composition affects antigen availability

  • Centrifugation to remove plant debris

  • Potential need for sample dilution to fit within standard curve

• Controls:

  • Include standard curve using recombinant protein

  • Include provided positive control antigen

  • Use pre-immune serum as negative control

• Detection system:

  • HRP-conjugated anti-rabbit secondary antibody typically at 1:5000-1:10000

  • TMB or ABTS substrate selection based on sensitivity requirements

  • Optimal development time determination

• Data analysis:

  • Establish 4-parameter logistic curve fit for quantification

  • Determine assay range, sensitivity, and reproducibility

  • Calculate coefficients of variation between replicates (<15% ideal)

This methodical approach to ELISA optimization ensures reliable and reproducible quantification of the target protein in complex plant samples.

What strategies can enhance signal detection when working with low-abundance Os01g0928700 protein samples?

Enhancing signal detection for low-abundance Os01g0928700 protein samples requires applying several advanced techniques:

• Sample enrichment strategies:

  • Immunoprecipitation to concentrate the target protein before analysis

  • Subcellular fractionation to isolate compartments where the protein may be concentrated

  • Protein precipitation techniques (TCA, acetone) to concentrate total protein

• Signal amplification methods:

  • Use tyramide signal amplification (TSA) for Western blotting or immunohistochemistry

  • Apply biotin-streptavidin amplification systems

  • Consider poly-HRP conjugated secondary antibodies

• Detection system optimization:

  • Select high-sensitivity chemiluminescent substrates (femtogram detection range)

  • Use fluorescent detection systems with appropriate filters

  • Extend exposure times while monitoring background

• Antibody optimization:

  • Increase primary antibody concentration or incubation time

  • Optimize blocking conditions to reduce background while preserving specific signal

  • Consider using affinity-purified antibody fractions

• Instrumentation considerations:

  • Use high-sensitivity imaging systems (cooled CCD cameras)

  • Apply image accumulation for weak signals

  • Utilize photomultiplier-based detection systems for ELISA

• Reduce background interference:

  • Add detergents (0.05-0.1% Tween-20) to reduce non-specific binding

  • Use specialized blocking agents for plant samples

  • Apply additional washing steps with optimized buffers

• Protocol modifications for low-abundance targets:

  • Extend primary antibody incubation to overnight at 4°C

  • Apply membrane stacking techniques for Western blotting

  • Consider using enhanced chemiluminescence plus (ECL+) detection systems

These approaches substantially improve detection sensitivity while maintaining specificity, enabling the study of low-abundance Os01g0928700 protein in various plant tissue samples.

How should experiments be designed to validate the specificity of Os01g0928700 antibody across different rice varieties?

Designing experiments to validate Os01g0928700 antibody specificity across different rice varieties requires a comprehensive approach:

• Sample selection strategy:

  • Include reference variety (Oryza sativa subsp. japonica) as positive control

  • Select diverse rice varieties: indica, japonica, aus, aromatic, and wild relatives

  • Sample multiple tissues (leaves, roots, seeds) from each variety

  • Collect samples at multiple developmental stages

• Genomic verification:

  • Sequence the Os01g0928700 gene region in test varieties

  • Perform in silico epitope analysis to predict antibody binding

  • Identify potential sequence variations affecting antibody recognition

• Protein extraction optimization:

  • Test multiple extraction protocols to ensure complete protein recovery

  • Normalize loading based on total protein quantification

  • Consider varietal differences in extraction efficiency

• Multi-method validation approach:

  • Western blotting with appropriate controls

  • ELISA quantification with standard curves

  • Immunoprecipitation followed by mass spectrometry

  • Immunohistochemistry for localization confirmation

• Controls and standards:

  • Recombinant Os01g0928700 protein as positive control

  • Pre-immune serum as negative control

  • Housekeeping proteins as loading controls

  • Competition assays with purified antigen

• Quantitative analysis:

  • Compare relative expression levels across varieties

  • Assess correlation between protein abundance and genetic distance

  • Calculate specificity and sensitivity metrics

This experimental design provides comprehensive validation of antibody specificity while accounting for natural variation in the target protein across rice diversity.

What controls are essential when using Os01g0928700 antibody in immunohistochemistry applications?

For immunohistochemistry (IHC) applications with Os01g0928700 antibody, the following controls are essential to ensure reliable and interpretable results:

• Primary antibody controls:

  • Positive tissue control: Samples known to express Os01g0928700 (specific rice tissues)

  • Negative tissue control: Samples known not to express the target protein

  • Antibody concentration series: To determine optimal dilution

  • Pre-immune serum control: Using the provided pre-immune serum

• Antigen-specific controls:

  • Peptide competition/neutralization: Pre-incubate antibody with excess immunizing antigen

  • Recombinant protein control: Using the provided antigen (200μg)

  • Genetic controls: If available, analyze knockout/knockdown plants lacking Os01g0928700

• Secondary antibody controls:

  • Secondary-only control: Omit primary antibody to assess non-specific binding

  • Isotype control: Non-specific rabbit IgG at the same concentration

  • Endogenous peroxidase blocking verification: If using HRP detection systems

• Tissue preparation controls:

  • Fixation controls: Comparison of different fixative effects on antigen preservation

  • Antigen retrieval optimization: Various methods to maximize epitope accessibility

  • Autofluorescence control: Untreated sections to assess plant tissue autofluorescence

• Cross-reactivity assessment:

  • Multi-species testing: Test antibody on related plant species

  • Dual staining: Co-localization with known markers if appropriate

• Procedural controls:

  • Reagent quality controls: Fresh reagents, proper storage verification

  • Protocol consistency: Standardized timing, temperatures, and conditions

  • Technical replicates: Multiple sections from the same sample

Incorporation of these controls ensures that the observed staining patterns are specific, reproducible, and truly representative of Os01g0928700 protein distribution within plant tissues.

How can researchers differentiate between true signal and background when analyzing Os01g0928700 expression in different subcellular compartments?

Differentiating between true signal and background when analyzing Os01g0928700 expression in subcellular compartments requires robust technical approaches:

• Subcellular fractionation verification:

  • Confirm fractionation purity using compartment-specific marker proteins:

    • Cytosol: Tubulin or GAPDH

    • Nucleus: Histone proteins

    • Chloroplast: Rubisco small subunit

    • Mitochondria: ATP synthase subunits

    • ER: BiP or calnexin

  • Western blot verification of fraction purity before Os01g0928700 analysis

• Signal validation approaches:

  • Serial dilution analysis of subcellular fractions

  • Competition assays with recombinant antigen in each fraction

  • Comparison of different detection methods (Western blot vs. immunofluorescence)

  • Co-localization with known subcellular markers

• Background reduction strategies:

  • Optimize blocking conditions for each subcellular fraction type

  • Pre-absorb antibody with fractions from negative control tissues

  • Increase washing stringency for problematic fractions

  • Use gradient purification to enhance compartment purity

• Quantitative assessment approaches:

  • Signal-to-noise ratio calculation for each compartment

  • Statistical comparison with negative controls

  • Normalization to compartment-specific loading controls

  • Multiple biological replicates with statistical analysis

• Complementary approaches:

  • Transgenic approaches with fluorescent protein fusions

  • In situ hybridization for mRNA localization correlation

  • Immunoelectron microscopy for highest resolution localization

  • Mass spectrometry analysis of immunoprecipitated complexes from individual fractions

These methodological approaches collectively provide robust differentiation between true signal and background, enabling accurate assessment of Os01g0928700 protein localization across subcellular compartments.

What are the key considerations for quantitative comparison of Os01g0928700 expression across developmental stages?

When conducting quantitative comparison of Os01g0928700 expression across developmental stages, researchers should consider several key factors:

• Sampling strategy:

  • Define clear developmental stages using standardized metrics

  • Collect samples at consistent times of day to control for circadian effects

  • Pool multiple biological replicates (minimum n=3) for each stage

  • Maintain consistent growth conditions across all developmental stages

• Extraction protocol standardization:

  • Use identical extraction buffers and procedures across all samples

  • Include protease inhibitors to prevent stage-specific degradation

  • Quantify total protein accurately for normalization

  • Process all samples simultaneously when possible

• Quantification approach selection:

  • ELISA: Most quantitative for absolute protein amounts

  • Western blotting with densitometry: Good for relative comparisons

  • Consider multiplexed approaches for simultaneous detection of target and controls

• Normalization strategies:

  • Total protein normalization (preferred)

  • Housekeeping protein controls with verified stability across development

  • Utilize multiple normalization references for cross-validation

• Statistical analysis:

  • Apply appropriate statistical tests for developmental series data

  • Consider using ANOVA with post-hoc tests for multi-stage comparisons

  • Calculate confidence intervals for expression measurements

  • Apply non-parametric tests if data don't meet normality assumptions

• Visualization methods:

  • Create developmental expression profiles with error bars

  • Use heatmaps for multi-tissue, multi-stage comparisons

  • Include statistical significance indicators

• Validation methods:

  • Correlate protein levels with transcript abundance (RT-qPCR)

  • Confirm patterns using alternative methods (e.g., immunohistochemistry)

  • Repeat experiments across different growing seasons or conditions

• Technical considerations:

  • Run standard curves on each ELISA plate

  • Include common samples across multiple blots/plates for inter-assay normalization

  • Document all analytical parameters for reproducibility

These considerations ensure robust quantitative comparison of Os01g0928700 expression throughout development, providing reliable insights into the protein's temporal regulation.

How should researchers troubleshoot unexpected or contradictory results when using the Os01g0928700 antibody?

When encountering unexpected or contradictory results with the Os01g0928700 antibody, researchers should follow this systematic troubleshooting approach:

• Technical validation:

  • Verify antibody quality: Check storage conditions, expiration, and potential contamination

  • Test antibody functionality using positive control antigen (provided 200μg)

  • Confirm secondary antibody specificity and activity

  • Perform antibody titration to identify optimal concentration

• Protocol examination:

  • Review each protocol step for deviations or errors

  • Check buffer compositions and pH values

  • Verify incubation times and temperatures

  • Assess blocking efficiency and washing stringency

• Sample-related investigations:

  • Examine sample preparation methods for potential protein degradation

  • Test fresh sample preparations

  • Consider protein extraction method compatibility with the target protein

  • Verify sample loading/concentration consistency

• Biological context analysis:

  • Review literature for potential post-translational modifications

  • Consider developmental or stress-induced protein isoforms

  • Investigate potential binding partners that might mask epitopes

  • Examine tissue-specific expression patterns

• Alternative methods comparison:

  • Compare results across different detection methods (ELISA, WB, IHC)

  • Use orthogonal approaches (mass spectrometry, RT-qPCR)

  • Consider genetic approaches (transgenic reporters, CRISPR knockout)

• Control expansions:

  • Include additional negative controls

  • Test across multiple rice varieties or related species

  • Perform competition assays with purified antigen

  • Use knockout/knockdown lines if available

• Documentation and consultation:

  • Document all experimental conditions precisely

  • Consult with antibody manufacturer regarding unexpected results

  • Seek input from colleagues with similar research systems

  • Compare with published literature using this antibody

This structured approach helps identify the source of unexpected results and guides appropriate modifications to experimental design, ultimately leading to more reliable and interpretable data.

What methods can be used to verify that observed signals truly represent Os01g0928700 rather than cross-reactive proteins?

Verifying that observed signals truly represent Os01g0928700 rather than cross-reactive proteins requires a multi-faceted validation approach:

• Antigen competition assays:

  • Pre-incubate antibody with excess purified recombinant Os01g0928700 protein

  • Observe signal elimination in competition condition

  • Perform dose-dependent competition with varying antigen concentrations

  • Use non-related protein as competition control

• Genetic validation approaches:

  • Test antibody on knockout or knockdown lines (CRISPR, RNAi)

  • Analyze overexpression lines for increased signal

  • Examine natural variants with known sequence differences

  • Use heterologous expression systems (e.g., Arabidopsis expressing rice Os01g0928700)

• Molecular weight verification:

  • Compare observed band size with predicted molecular weight

  • Account for post-translational modifications

  • Perform 2D electrophoresis to separate by both pI and size

  • Use gradient gels for higher resolution molecular weight separation

• Mass spectrometry validation:

  • Immunoprecipitate using Os01g0928700 antibody

  • Analyze precipitated proteins by LC-MS/MS

  • Confirm Os01g0928700 peptide sequences in precipitated material

  • Identify any co-precipitating proteins that might contribute to signal

• Multi-antibody approach:

  • If available, test multiple antibodies against different epitopes of Os01g0928700

  • Compare signal patterns across antibodies

  • Create epitope-mapped antibody panel if resources permit

• Signal correlation analysis:

  • Correlate protein levels with mRNA expression (RT-qPCR)

  • Compare patterns across tissues and conditions

  • Assess whether signal changes align with expected biological regulation

• Cross-reactivity assessment:

  • Test antibody on related rice proteins expressed in heterologous systems

  • Perform epitope mapping through peptide arrays

  • Use bioinformatics to identify potential cross-reactive proteins

These rigorous validation approaches collectively provide strong evidence that the observed signals represent true Os01g0928700 protein rather than cross-reactive artifacts.